School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China.
J Ethnopharmacol. 2021 Mar 1;267:113475. doi: 10.1016/j.jep.2020.113475. Epub 2020 Oct 14.
Coronary heart disease (CHD) usually refers to myocardial ischemia or myocardial necrosis caused by coronary artery stenosis. GeGen and DanShen (GD) are popular Chinese herbs for the treatment of angina pectoris and myocardial infarction (MI). This sentence needs to be a separate paragraph.
This study was to investigate the role of GD extract in promoting ischemic myocardial angiogenesis, and to explore its signaling mechanism, so as to provide a more reliable scientific basis for the clinical treatment of ischemic cardiovascular disease.
GD extract was initially analyzed by HPLC-Q-TOF MS. In vitro, migration assay and tube formation assay were subsequently used to detect the angiogenesis activity of GD extract in human umbilical vein endothelial cells (HUVECs). Following the in vitro study, an MI rat model was established by ligating the left anterior descending coronary artery (LAD), immediately followed by a 4-week daily GD extract treatment by intragastric administration. After the animal sacrifice, hematoxylin-eosin (HE) staining was conducted to observe the pathological changes of the infarct margin. Besides, the MI area was measured by 2,3,5-triphenyltetrazoliumchloride (TTC) staining. The microvascular density (MVD) was also quantified through CD31 immunohistochemistry. Moreover, the levels of VEGF, TXB2 and 6-keto-PGF1α in serum were detected by enzyme-linked immunosorbent assay. The expression of VEGFR2 and ERK were detected by immunohistochemistry as well.
In vitro study, GD extract was found to induce significant angiogenesis in HUVECs. In vivo, smaller infarct size was found in treatment groups than that of the model group, and the protein expression of VEGFR2 as well as ERK in the marginal zone of MI in treatment groups were significantly increased. The morphological changes of myocardium were observed with a significant growth in the number of new blood vessels. Regarding the effect of GD extract, the serum levels of CK, LDH and TXB2 were consequently reduced, whereas the levels of VEGF, 6-keto-PGF1α were significantly increased.
Based on the findings of this study, GD extract had a protective effect against MI in rats. The possible mechanism is to promote angiogenesis by regulating the VEGF/VEGFR2 signaling pathway after MI occurrence.
标题 民族药理学相关性:冠心病(CHD)通常指因冠状动脉狭窄导致的心肌缺血或心肌坏死。葛根和丹参(GD)是治疗心绞痛和心肌梗死(MI)的常用中药。
目的 本研究旨在探讨 GD 提取物在促进缺血性心肌血管生成中的作用,并探讨其信号机制,为缺血性心血管疾病的临床治疗提供更可靠的科学依据。
材料和方法 首先用高效液相色谱-四极杆飞行时间质谱(HPLC-Q-TOF MS)对 GD 提取物进行初步分析。然后,在体外通过迁移实验和管形成实验检测 GD 提取物对人脐静脉内皮细胞(HUVEC)的血管生成活性。在体外研究之后,通过结扎左前降支冠状动脉(LAD)建立 MI 大鼠模型,随后通过灌胃给予 GD 提取物进行为期 4 周的每日治疗。动物处死时,进行苏木精-伊红(HE)染色观察梗死边缘的病理变化。此外,通过 2,3,5-三苯基氯化四氮唑(TTC)染色测量 MI 面积。通过 CD31 免疫组化定量微血管密度(MVD)。此外,通过酶联免疫吸附试验检测血清中 VEGF、TXB2 和 6-酮-PGF1α 的水平。通过免疫组化检测 VEGFR2 和 ERK 的表达。
结果 体外研究发现,GD 提取物可诱导 HUVEC 显著血管生成。体内研究发现,治疗组的梗死面积小于模型组,治疗组 MI 边缘区 VEGFR2 和 ERK 的蛋白表达明显增加。观察到心肌形态发生变化,新血管数量明显增加。关于 GD 提取物的作用,血清 CK、LDH 和 TXB2 水平降低,而 VEGF、6-酮-PGF1α 水平升高。
结论 基于本研究的结果,GD 提取物对大鼠 MI 具有保护作用。其可能的机制是通过调节 MI 发生后的 VEGF/VEGFR2 信号通路促进血管生成。